Autologous NK Cell Therapy with complete in-house CPC management from blood collection and cell culture to administration, with the clinic director overseeing both patient care and cell quality control.

Motif Ginza Clinic's Autologous NK Cell Therapy is a regenerative medicine treatment in which NK (Natural Killer) cells collected from the patient's own blood are cultured in the clinic's in-house Cell Processing Center (CPC) and administered by intravenous infusion.

This therapy is intended for individuals with concerns about reduced immune function, those who experience chronic fatigue or are prone to infections, and patients seeking supportive immune management after cancer treatment. A physician will determine whether the therapy is appropriate for each patient.

The entire process—from blood collection, cell culture, quality control, and administration—is managed within the clinic's in-house CPC. The clinic director personally oversees both patient care and the verification of cell quality.

Approximately 30 mL of blood is collected for cell culture. The culture period is approximately 4 weeks, and the NK cells are administered by intravenous infusion over approximately 60 minutes.

When combined with stem cell therapy, the timing of administration is individually adjusted according to the patient's condition and treatment objectives.

Program details

【Treatment Schedule】
Day 1
Medical consultation
Eligibility assessment
Blood collection

After Blood Collection
NK cells are cultured in the clinic's in-house CPC for approximately 4 weeks

Approximately 4 Weeks Later
Administration by intravenous infusion

Administration Time
Approximately 60 minutes

After Treatment
Follow-up evaluation as needed

The treatment date will be scheduled after confirming both the cell culture schedule and the clinic's appointment availability.

When combined with stem cell therapy, the interval between treatments will be determined individually by the physician.

Providing Medical Institution

Motif GINZA Clinic.

〒104-0061
4th Floor and 9th Floor, Ginza Kawai Building, 1-7-6 Ginza, Chuo-ku Tokyo

https://regenerative.motif-ginza.com/

Specialty

・Autologous adipose-derived stem cell therapy for chronic pain
・Autologous adipose-derived stem cell therapy for osteoarthritis
・Autologous adipose-derived stem cell therapy for skin aging and photoaging
・NK cell therapy for cancer treatment, cancer prevention, and improvement of immune function
・Autologous adipose-derived stem cell therapy for alopecia
・Autologous adipose-derived stem cell therapy for type 2 diabetes mellitus and prediabetes
・Autologous adipose-derived stem cell therapy for atherosclerosis
・Autologous adipose-derived stem cell therapy for menopausal disorders and decreased ovarian function

Eligibility Criteria/Exclusions for Treatment

A physician will determine whether treatment can be provided and whether the patient is eligible after reviewing the medical consultation, medical history, current medications, overall health condition, blood test results, and other relevant medical information.

The following information must be confirmed in advance:

Purpose of treatment
Target treatment area
Medical history
Current medications
Presence of infectious diseases
Use of anticoagulant medications
Possibility of pregnancy

If you plan to visit the clinic using a wheelchair, please contact the clinic in advance.

Precautions / Contraindications

Treatment may require prior evaluation or postponement depending on the presence of an infectious disease, a serious systemic medical condition, the possibility of pregnancy, the patient's medical history, current medications, or other relevant medical factors.